July 7 (Reuters) - Kailera Therapeutics' oral obesity drug helped patients lose up to 10.9% of their body weight at week 44 ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

For years, GLP-1 drugs like Wegovy and Zepbound have transformed the discussion around obesity — but left millions locked out ...

GLP-1 weight-loss drugs will cost $50 a month for many older adults starting July 1, as Medicare begins to cover them. How ...

New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored ...

Starting July 1, about 14 million people on Medicare who have been diagnosed as obese or overweight will be eligible for $50 GLP-1 drugs, ...

India, July 6 -- The Wegovy weight loss pill has officially launched in the UK, marking the country's first GLP-1 weight-loss ...

Fridays is a telehealth platform offering GLP-1 weight loss medications through a subscription model. The service provides both brand-name drugs like Ozempic and cheaper, non-FDA-approved compounded ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...

What if the most important lesson from the rise of GLP-1 weight-loss drugs isn’t medical but economic? Like millions of Americans, I’ve benefitted from the price war between the two pharmaceutical ...

Thousands of older Oregonians could soon pay just $50 a month for popular weight loss drugs that have previously been out of ...

Kailera Therapeutics' oral obesity drug helped patients lose up to 10.9% of their body weight at week 44 in a late-stage ...